Antioxidants regulators in VALI
VALI 中的抗氧化剂调节剂
基本信息
- 批准号:6820148
- 负责人:
- 金额:$ 20.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-30 至 2008-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The overall aim of this SCCOR application is to understand the complex events related to ventilator-associated lung injury (VALI). In Project 6, we will determine the role of oxidative stress in VALI. Oxidative stress has been generally implicated in acute lung injury through production of reactive oxygen species (ROS). To detoxify ROS, lung cells express a network of integrated antioxidant enzymes (AOE) consisting of both classical and phase II detoxifying enzymes. However, if the oxidant stress is overwhelming, ROS may suppress or inactivate the AOE system resulting in cellular damage. We have recently shown by genetic and
functional analysis that NF-E2 related factor 2 (Nrf2) plays a critical role in hyperoxia-induced lung injury. This transcription factor is involved in lung epithelial cell repair and stretch and regulates the induction of phase II AOEs. We have also shown that Nrf2-knockout mice are more susceptible to hyperoxia-induced lung injury. In collaboration with the various Cores of the SCCOR, genomic analysis revealed an upregulation of Nrf2 and AP-1 family members, such as fos-related protein-1 (Fra-1), as well as specific AOEs in the lungs of mice and dogs exposed to mechanical ventilation (MV). Thus, we hypothesize that activation of transcription factors such as Nrf2 and Fra-1 and their downstream effectors plays a critical role in the modulation of VALI. To test this hypothesis, we propose the following Specific Aims: 1) Determine the molecular responses of the lung in response to MV and hyperoxia in the development of VALI. We will compare gene and protein expression profiles and markers of injury in the lungs of mice and
dogs exposed to MV and hyperoxia; 2) Examine the role of Nrf2 and identify its downstream effectors in VALI; and 3) Examine the role of Fra-1 and identify its downstream effectors in VALI. For these studies, we will use respective knockout and/or transgenic mice with specific lung overexpression of mutant or wildtype proteins of Nrf2 and Fra-1, as well as genomics and proteomics techniques in collaboration with the various Cores. Cross species comparison and validation of these results in human will be done through collaboration with other Basic and Clinical Research Projects, respectively. Results of these studies will provide further insight into the role of oxidative stress as well as the molecular and genetic basis of VALI. The identification
of molecular targets will aid in the development of new strategies aimed at minimizing the potential I hazardous effects of MV and hyperoxia.
本SCCOR应用程序的总体目标是了解与呼吸机相关肺损伤(VALI)相关的复杂事件。在项目6中,我们将确定氧化应激在VALI中的作用。氧化应激通常通过产生活性氧(ROS)参与急性肺损伤。为了解毒ROS,肺细胞表达由经典解毒酶和II相解毒酶组成的集成抗氧化酶(AOE)网络。然而,如果氧化应激是压倒性的,ROS可能会抑制或破坏AOE系统,导致细胞损伤。我们最近通过基因和
NF-E2相关因子2(Nrf 2)在高氧肺损伤中起重要作用。该转录因子参与肺上皮细胞修复和伸展,并调节II相AOE的诱导。我们还表明,Nrf 2基因敲除小鼠更容易受到高氧诱导的肺损伤。与SCCOR的各种核心合作,基因组分析揭示了Nrf 2和AP-1家族成员的上调,如Fos相关蛋白-1(Fra-1),以及暴露于机械通气(MV)的小鼠和犬肺中的特定AOE。因此,我们假设转录因子如Nrf 2和Fra-1及其下游效应子的激活在VALI的调节中起关键作用。为了验证这一假设,我们提出了以下具体目标:1)确定肺对VALI发展中MV和高氧的分子反应。我们将比较小鼠肺损伤的基因和蛋白质表达谱以及标记物,
暴露于MV和高氧的狗; 2)检查Nrf 2的作用并鉴定其在VALI中的下游效应物;和3)检查Fra-1的作用并鉴定其在VALI中的下游效应物。对于这些研究,我们将使用相应的基因敲除和/或转基因小鼠与特定的肺过表达的突变体或野生型蛋白的Nrf 2和Fra-1,以及基因组学和蛋白质组学技术与各种核心合作。这些结果在人体中的跨物种比较和验证将分别通过与其他基础和临床研究项目的合作进行。这些研究的结果将提供进一步了解氧化应激的作用以及VALI的分子和遗传基础。识别
分子靶点的研究将有助于开发新的策略,旨在最大限度地减少MV和高氧的潜在危险作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sekhar P. Reddy其他文献
Sekhar P. Reddy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sekhar P. Reddy', 18)}}的其他基金
Role of Nrf2 in Alveolar Epithelial Cell Regeneration During Lung Repair
Nrf2 在肺修复过程中肺泡上皮细胞再生中的作用
- 批准号:
10025798 - 财政年份:2020
- 资助金额:
$ 20.95万 - 项目类别:
Role of Nrf2 in Alveolar Epithelial Cell Regeneration During Lung Repair
Nrf2 在肺修复过程中肺泡上皮细胞再生中的作用
- 批准号:
9289190 - 财政年份:2017
- 资助金额:
$ 20.95万 - 项目类别:
Fra-1-A20 Signaling and Resolution of Pneumonia-Induced Sepsis
Fra-1-A20 信号传导和肺炎引起的败血症的解决
- 批准号:
9906946 - 财政年份:2017
- 资助金额:
$ 20.95万 - 项目类别:
ROLE OF NRF2 IN ALVEOLAR EPITHELIAL REGENERATION DURING LUNG REPAIR
NRF2 在肺修复过程中肺泡上皮再生中的作用
- 批准号:
9351722 - 财政年份:2017
- 资助金额:
$ 20.95万 - 项目类别:
Targeting Fra-1 in Toxicant-Induced Lung Tumor Initiation & Development
靶向 Fra-1 参与毒物诱导的肺肿瘤发生
- 批准号:
8212283 - 财政年份:2011
- 资助金额:
$ 20.95万 - 项目类别:
Targeting Fra-1 in Toxicant-Induced Lung Tumor Initiation & Development
靶向 Fra-1 参与毒物诱导的肺肿瘤发生
- 批准号:
8049523 - 财政年份:2011
- 资助金额:
$ 20.95万 - 项目类别:
Targeting Fra-1 in Toxicant-Induced Lung Tumor Initiation & Development
靶向 Fra-1 参与毒物诱导的肺肿瘤发生
- 批准号:
8268753 - 财政年份:2011
- 资助金额:
$ 20.95万 - 项目类别:
The Role and Biology of Fra-1 in Lung Injury and Repair
Fra-1 在肺损伤和修复中的作用和生物学
- 批准号:
7847936 - 财政年份:2009
- 资助金额:
$ 20.95万 - 项目类别:
The Role and Biology of Fra-1 in Lung Injury and Repair
Fra-1 在肺损伤和修复中的作用和生物学
- 批准号:
8265096 - 财政年份:2002
- 资助金额:
$ 20.95万 - 项目类别:
相似海外基金
Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
- 批准号:
24K18002 - 财政年份:2024
- 资助金额:
$ 20.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
- 批准号:
2222215 - 财政年份:2023
- 资助金额:
$ 20.95万 - 项目类别:
Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
- 批准号:
23K09272 - 财政年份:2023
- 资助金额:
$ 20.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
- 批准号:
10652764 - 财政年份:2023
- 资助金额:
$ 20.95万 - 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
- 批准号:
10730652 - 财政年份:2023
- 资助金额:
$ 20.95万 - 项目类别:
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
- 批准号:
22K11609 - 财政年份:2022
- 资助金额:
$ 20.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
- 批准号:
22K16720 - 财政年份:2022
- 资助金额:
$ 20.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
- 批准号:
RGPIN-2018-04107 - 财政年份:2022
- 资助金额:
$ 20.95万 - 项目类别:
Discovery Grants Program - Individual
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
- 批准号:
RGPIN-2019-05674 - 财政年份:2022
- 资助金额:
$ 20.95万 - 项目类别:
Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
- 批准号:
22K12824 - 财政年份:2022
- 资助金额:
$ 20.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)